Women, Sex/Gender Differences and Drug Abuse (R21)

The summary for the Women, Sex/Gender Differences and Drug Abuse (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Women, Sex/Gender Differences and Drug Abuse (R21): The purpose of this Funding Opportunity Announcement (FOA) is to encourage sex/gender-based drug abuse research that focuses on the mechanisms, origins, and consequences of drug abuse, as well as prevention and treatment interventions and services. It also encourages the study of female-specific issues in all areas of drug abuse. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards are contingent upon the availability of funds and the quality, duration, and costs of the applications received. -This FOA will use the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-06-332, that solicits applications under the Small Research Grant (R03) award mechanism. Applicants wishing to submit applications under the traditional Research Project Grant (R01) mechanism are referred to the initial funding opportunity, PA-03-139. - Budget and Project Period: The total project period for an application submitted in response to this finding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. . - Eligible Organizations: For-profit and non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government ; domestic and foreign institutions/organizations; faith-based or community-based organizations; units of State Tribal government; and units of Local Tribal government. - Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct
Federal Grant Title: Women, Sex/Gender Differences and Drug Abuse (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-06-331
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Apr 06, 2006
Creation Date: Apr 06, 2006
Archive Date: Jul 30, 2006
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Native American tribal governments (Federally recognized) Independent school districts For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments Private institutions of higher education Special district governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com